Biblio

Export 421 results:
Author [ Keyword(Desc)] Title Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Alzheimer Disease
U. Rüb, Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., and Korf, H. - W., Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches., J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
F. T. Hane, Robinson, M., Lee, B. Y., Bai, O., Leonenko, Z., and Albert, M. S., Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment., J Alzheimers Dis, vol. 57, no. 3, pp. 645-665, 2017.
M. A. Beydoun, Gamaldo, A. A., Beydoun, H. A., Shaked, D., Zonderman, A. B., and Eid, S. M., Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample., J Alzheimers Dis, vol. 57, no. 3, pp. 813-824, 2017.
E. J. Mason, Hussey, E. P., Molitor, R. J., Ko, P. C., Donahue, M. J., and Ally, B. A., Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects., J Alzheimers Dis, vol. 57, no. 3, pp. 735-745, 2017.
J. Cummings, Ritter, A., and Zhong, K., Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future., J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
P. Chatterjee, Roy, D., and Rathi, N., Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome., J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
L. Su, Hayes, L., Soteriades, S., Williams, G., Brain, S. A. E., Firbank, M. J., Longoni, G., Arnold, R. J., Rowe, J. B., and O'Brien, J. T., Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 1, pp. 415-424, 2018.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms., J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
C. Lange, Suppa, P., Pietrzyk, U., Makowski, M. R., Spies, L., Peters, O., and Buchert, R., Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status., J Alzheimers Dis, vol. 61, no. 1, pp. 373-388, 2018.
G. Cuberas-Borrós, Roca, I., Boada, M., Tárraga, L., Hernandez, I., Buendia, M., Rubio, L., Torres, G., Bittini, Á., Guzmán-de-Villoria, J. A., Pujadas, F., Torres, M., Núñez, L., Castell, J., and Páez, A., Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin., J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
Y. Hasegawa, Toyama, K., Uekawa, K., Ichijo, H., and Kim-Mitsuyama, S., Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 259-263, 2018.
K. Steen Frederiksen, Gjerum, L., Waldemar, G., and Hasselbalch, S. Gregers, Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies., J Alzheimers Dis, vol. 61, no. 1, pp. 359-372, 2018.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial., J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
C. M. Huber, Yee, C., May, T., Dhanala, A., and Mitchell, C. S., Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy., J Alzheimers Dis, vol. 61, no. 1, pp. 265-281, 2018.
S. Gelman, Palma, J., Tombaugh, G., and Ghavami, A., Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 195-208, 2018.
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S., Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
J. Paulo Alme Santos, Vizuete, A., Hansen, F., Biasibetti, R., and Gonçalves, C. - A., Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 237-249, 2018.
N. Y. Kirson, J Andrews, S., Desai, U., King, S. B., Schonfeld, S., Birnbaum, H. G., Ball, D. E., and Kahle-Wrobleski, K., Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 295-307, 2018.
J. A. Matías-Guiu, Cabrera-Martín, M. Nieves, Curiel, R. E., Valles-Salgado, M., Rognoni, T., Moreno-Ramos, T., Carreras, J. Luis, Loewenstein, D. A., and Matías-Guiu, J., Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
J. Gustavo Villamil-Ortiz, Barrera-Ocampo, A., Arias-Londoño, J. David, Villegas, A., Lopera, F., and Cardona-Gómez, G. Patricia, Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains., J Alzheimers Dis, vol. 61, no. 1, pp. 209-219, 2018.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
V. Andrew Fajardo, Fajardo, V. Andrei, LeBlanc, P. J., and MacPherson, R. E. K., Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas., J Alzheimers Dis, vol. 61, no. 1, pp. 425-434, 2018.
C. M. Black, Fillit, H., Xie, L., Hu, X., M Kariburyo, F., Ambegaonkar, B. M., Baser, O., Yuce, H., and Khandker, R. K., Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 185-193, 2018.

Pages